Open AccessP515: LOWER‐INTENSITY CPX‐351 + VENETOCLAX FOR PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA WHO ARE UNFIT FOR INTENSIVE CHEMOTHERAPY
Author(s) -
Uy G. L.,
Pullarkat V. A.,
Baratam P.,
Stuart R. K.,
Walter R. B.,
Winer E. S.,
Faderl S.,
Chandrasekaran V.,
Wang Q.,
Chakravarthy D.,
Cheung R. S.,
Lin T. L.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000844948.28359.0b
Subject(s) - medicine , cytarabine , venetoclax , ven , chemotherapy regimen , oncology , myeloid leukemia , chemotherapy , leukemia , chronic lymphocytic leukemia , computer security , computer science